They'll probably suggest using that pen first and starting the 56-day countdown from when it was first left out
In findings from a microsimulation model published in JAMA Health Forum , semaglutide (Wegovy, Novo Nordisk) had the highest incremental cost-effectiveness ratio (ICER) of four obesity medications assessed in the study, and tirzepatide (Zepbound, Eli Lilly) had the second-highest ICER
When combined with healthy lifestyle changes, it can help patients achieve more significant and lasting results than with lifestyle modification alone
Key Takeaways: Wegovy vs Ozempic Both medications contain identical active ingredient: semaglutide Wegovy is FDA-approved for weight loss, Ozempic is approved for type 2 diabetes Wegovys maximum dose is 2.4 mg weekly, Ozempic tops out at 2 mg weekly Clinical trials showing 14.9% average weight loss used Wegovys 2.4 mg dose Wegovy costs $1,349/month, Ozempic costs $969/month (both without insurance) Insurance often covers Ozempic for diabetes but denies Wegovy for weight loss Compounded semaglutide at $199/month offers same benefits at fraction of the cost Both cause similar side effects: nausea, diarrhea, constipation The Basics: What Are Wegovy and Ozempic
Other medications may be used for different medical purposes or may be prescribed off-label when clinically appropriate